64
Views
8
CrossRef citations to date
0
Altmetric
Review

Controlled-release carvedilol in the management of systemic hypertension and myocardial dysfunction

, &
Pages 1387-1400 | Published online: 05 Dec 2008

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Gastone Leonetti & Colin G Egan. (2012) Use of carvedilol in hypertension: an update. Vascular Health and Risk Management 8, pages 307-322.
Read now
James J DiNicolantonio & Daniel G Hackam. (2012) Carvedilol: a third-generation β-blocker should be a first-choice β-blocker. Expert Review of Cardiovascular Therapy 10:1, pages 13-25.
Read now

Articles from other publishers (6)

Francesco Fici, Nicolas Roberto Robles, Istemihan Tengiz & Guido Grassi. (2023) Beta-Blockers and Hypertension: Some Questions and Answers. High Blood Pressure & Cardiovascular Prevention.
Crossref
Rui Zhang, Ling-Jun Jie, Wei-Yin Wu, Zhi-Quan Wang, Hai-Ying Sun, Guo-Sheng Xiao, Yan Wang, Yi-Gang Li & Gui-Rong Li. (2019) Comparative study of carvedilol and quinidine for inhibiting hKv4.3 channel stably expressed in HEK 293 cells. European Journal of Pharmacology 853, pages 74-83.
Crossref
Nicolaos Scoutaris, Maria Malamatari, Adrien Letellier & Dennis Douroumis. (2017) Jet dispensing of multi-layered films for the co-delivery of three antihypertensive agents. Drug Delivery and Translational Research 8:1, pages 32-42.
Crossref
Cátia V. Diogo, Cláudia M. Deus, Magdalena Lebiedzinska-Arciszewska, Aleksandra Wojtala, Mariusz R. Wieckowski & Paulo J. Oliveira. (2017) Carvedilol and antioxidant proteins in a type I diabetes animal model. European Journal of Clinical Investigation 47:1, pages 19-29.
Crossref
Nathalie Moise, Joseph Schwartz, Rachel Bring, Daichi Shimbo & Ian M. Kronish. (2015) Antihypertensive Drug Class and Adherence: An Electronic Monitoring Study. American Journal of Hypertension 28:6, pages 717-721.
Crossref
Junmin Yu, Jiyi Zhao, Wei Liu, Zhenzhong Ge & Yongli Du. (2011) Combined effects of irbesartan and carvedilol on expression of tissue factor and tissue factor pathway inhibitor in rats after myocardial infarction. Heart and Vessels 26:6, pages 646-653.
Crossref